Low Prevalence of HER2-Positive Breast Carcinomas among Screening Detected Breast Cancers

Conflicting results have been reported regarding the prevalence of screen-detected human epidermal growth factor receptor 2 (HER2)-positive breast carcinomas and non-screen detected HER2-positive breast carcinomas. To address this issue, we evaluated the prevalence of HER2-positive breast carcinomas...

Descripción completa

Detalles Bibliográficos
Autores principales: López-García, M. Ángeles, Carretero-Barrio, Irene, Pérez-Míes, Belén, Chiva, Miguel, Castilla, Carolina, Vieites, Begoña, Palacios, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352518/
https://www.ncbi.nlm.nih.gov/pubmed/32549380
http://dx.doi.org/10.3390/cancers12061578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352518/
https://www.ncbi.nlm.nih.gov/pubmed/32549380
http://dx.doi.org/10.3390/cancers12061578

Ejemplares similares